Massive infiltration of bone marrow in colon carcinoma after treatment with activated protein C

被引:9
|
作者
Pleyer, Lisa
Went, Philip
Russ, Gudrun
Prinz, Erika
Faber, Viktoria
Roewert, Hans-Joachim
Karlbauer, Renate
Greil, Richard
机构
[1] Private Med Paracelsus Univ Salzburg, Med Dept Hematol Med Oncol Hemostaseol Rheumatol, A-5020 Salzburg, Austria
[2] Private Med Paracelsus Univ Salzburg, Dept Pathol, A-5020 Salzburg, Austria
[3] Private Med Paracelsus Univ Salzburg, Dept Anesthesiol, A-5020 Salzburg, Austria
[4] Univ Basel Hosp, Dept Pathol, CH-4031 Basel, Switzerland
关键词
activated protein C; bone marrow infiltration; colorectal cancer; sepsis;
D O I
10.1007/s00508-007-0774-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We present an unusual case of localized colorectal carcinoma complicated by sepsis which was treated with activated protein C (APC). Shortly after treatment the patient developed symptomatic metastases to the bone marrow (BM). Destruction of bones by colorectal cancer (CRC) is rare, although BM micrometastases are frequently observed. However, overt symptomatic BM metastasis is an exotic rarity. APC interacts with molecules and modulates pathways that are unquestionably involved in tumorigenesis and formation of metastases. Therefore a possible contributory role of the anti-inflammatory and immunomodulatory therapy in the rapid evolution of the disease cannot be excluded. Questions concerning the relevance and contribution of sepsis, treatment with APC, exquisitely high levels of non-thrombosis-associated D-dimer and CA19-9 to this highly uncommon course of disease are discussed. The lesson learned from this case is that APC may have contributed to the massive invasion of BM by colonic cancer cells in our patient and that APC should therefore be used with extreme restraint in patients with potentially curable cancer.
引用
收藏
页码:254 / 258
页数:5
相关论文
共 50 条
  • [21] Role of coagulation pathways and treatment with activated protein C in hyperoxic lung injury
    Looney, M. R.
    Esmon, C. T.
    Matthay, M. A.
    THORAX, 2009, 64 (02) : 114 - 120
  • [22] Drotrecogin alfa (recombinant human activated protein C) for the treatment of severe sepsis
    McCoy, C
    Matthews, SJ
    CLINICAL THERAPEUTICS, 2003, 25 (02) : 396 - 421
  • [23] Randomized clinical trial of activated protein C for the treatment of acute lung injury
    Liu, Kathleen D.
    Levitt, Joseph
    Zhuo, Hanjing
    Kallet, Richard H.
    Brady, Sandra
    Steingrub, Jay
    Tidswell, Mark
    Siegel, Mark D.
    Soto, Graciela
    Peterson, Michael W.
    Chesnutt, Mark S.
    Phillips, Charles
    Weinacker, Ann
    Thompson, B. Taylor
    Eisner, Mark D.
    Matthay, Michael A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 178 (06) : 618 - 623
  • [24] Activated protein C attenuates intestinal mucosal injury after mesenteric ischemia/reperfusion
    Teke, Zafer
    Sacar, Mustafa
    Yenisey, Cigdem
    Atalay, Ozgur
    Kavak, Tulay
    Erdem, Ergun
    JOURNAL OF SURGICAL RESEARCH, 2008, 149 (02) : 219 - 230
  • [25] Inhibitory effect of activated protein C on cerebral vasospasm after subarachnoid Hemorrhage in the rabbit
    Mizuno, Y
    Azuma, H
    Ito, Y
    Isotani, E
    Ohno, K
    Hirakawa, K
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2002, 39 (05) : 729 - 738
  • [26] Adventure of Recombinant Human Activated Protein C in Sepsis and New Treatment Hopes on the Horizon
    Kaya, Selcuk
    RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY, 2012, 6 (02) : 159 - 164
  • [27] Activated Protein C (APC) can Increase Bone Anabolism via a Protease-Activated Receptor (PAR) 1/2 Dependent Mechanism
    Shen, Kaitlin
    Murphy, Ciara M.
    Chan, Ben
    Kolind, Mille
    Cheng, Tegan L.
    Mikulec, Kathy
    Peacock, Lauren
    Xue, Meilang
    Park, Sang-Youel
    Little, David G.
    Jackson, Chris J.
    Schindeler, Aaron
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2014, 32 (12) : 1549 - 1556
  • [28] Old drug, new Trick? The rationale for the treatment of COVID-19 with activated protein C
    Pestka, Steven B.
    MEDICAL HYPOTHESES, 2021, 149
  • [29] Comment on "Early treatment with activated protein C for meningococcal septic shock: case report and literature review" by Hasin et al.
    Thomas, GL
    Clark, P
    INTENSIVE CARE MEDICINE, 2005, 31 (12) : 1729 - 1729
  • [30] Comment on “Early treatment with activated protein C for meningococcal septic shock: case report and literature review” by Hasin et al.
    Gareth L. Thomas
    Peter Clark
    Intensive Care Medicine, 2005, 31 : 1729 - 1729